Recruiting
Phase 1
Phase 2

A Study to Evaluate the Safety of CMTX-101 in People with Cystic Fibrosis

Sponsor:

Clarametyx Biosciences, Inc.

Code:

NCT06159725

Conditions

Persistent Infection

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CMTX-101

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information